ESTABLISHED IN 2019

Our Team.

Our Expertise.

Biology & Synthesis

The basics for drug discovery

As pioneers for membrane protein research, we understand the biology, the production of tough targets & of any antibody drug format using our optimized workflows.

Candidate identification

You get what you select for.

Our immunization & display experience helps us determine what's next, evolving our Sybody strategies to identify best, potent & conformation-selective antibodies.

Characterize & Screen

Giving direction.

We are raising the bar & eliminate classical triaging by using our revolutionary Flycode screening technology to include pre-clinical development from the start.

Preclinical development

In vivo drug discovery revolution.

Our team of Flycode champions optimizes the in vivo properties of clinical candidates with a throughput of hundreds of antibodies in just 1 animal.

Partner excellence

Bridging innovation.

The world isn't short on ideas & cutting-edge research that we understand, value & implement seamlessly in our processes or perform together with our strong partners.

Therapeutic efficacy

The patients benefit is our ambition.

We create key experiments & tangible results to determine the therapeutic performance of candidates, advocate for or against them & mitigate occurring risks.

Previous slide

Next slide

Linkster Therapeutics is a university spin-off
in Zurich, Switzerland.

Markus Seeger Founder

more about us.

We looking forward to working with you.

ESTABLISHED IN 2019

Our Team.

Iwan Zimmermann

Roger Dawson

Our Expertise.

more about us.

Get in Touch

Where we are

Quick Links